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Abstract: The pattern of metabolites produced by the gut microbiome comprises a 
phenotype indicative of the means by which that microbiome affects the gut. We 
characterized that phenotype in mice by conducting metabolomic analyses of the  
colonic-cecal contents, comparing that to the metabolite patterns of feces in order to 
determine the suitability of fecal specimens as proxies for assessing the metabolic impact of 
the gut microbiome. We detected a total of 270 low molecular weight metabolites in  
colonic-cecal contents and feces by gas chromatograph, time-of-flight mass spectrometry 
(GC-TOF) and ultra-high performance liquid chromatography, quadrapole time-of-flight 
mass spectrometry (UPLC-Q-TOF). Of that number, 251 (93%) were present in both types 
of specimen, representing almost all known biochemical pathways related to the amino acid, 
carbohydrate, energy, lipid, membrane transport, nucleotide, genetic information processing, 
and cancer-related metabolism. A total of 115 metabolites differed significantly in relative 
abundance between both colonic-cecal contents and feces. These data comprise the first 
characterization of relationships among metabolites present in the colonic-cecal contents and 
feces in a healthy mouse model, and shows that feces can be a useful proxy for assessing the 
pattern of metabolites to which the colonic mucosum is exposed. 
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1. Introduction 
The gastrointestinal tract, which is the site of the host’s first encounter with nutrients, microorganisms 
and other bioactive factors in foods, hosts a complex community of microorganisms. The role of that 
community in affecting health is becoming increasingly evident. Research has shown that differences in 
the nature of the gut microbiome are associated with risk to obesity [1], colon cancer [2], and type 2 diabetes 
mellitus [3]. Such effects would appear to involve the production by the gut microbiome of metabolites used 
as substrates and/or signaling molecules by mucosal epithelial cells. 
Metabolites represent molecular read-outs of cells. The pattern of metabolites produced by the gut 
microbiome comprises a phenotype indicative of the means by which that microbiome affects the gut. 
Such metabolic phenotypes can be characterized using metabolomic approaches, which employ the 
capacities of tandem liquid/gas chromatography-mass spectrometry to profile metabolites. 
Two major platforms are available for metabolomic analyses: gas chromatography, time-of-flight 
mass spectrometry (GC-TOF) and liquid chromatography quadrapole, time-of-flight mass spectrometry 
(LC-Q-TOF). The former is useful for the analysis of thermally stable volatile compounds, typically 
>600 daltons, and yields high separation efficiency and reproducible retention times and mass spectra. 
The latter does not require derivatization, and is amenable for the analysis of polar and high molecular 
weight metabolites [4,5]. Combining data produced by both platforms offers comprehensive insight into 
actual metabolomic phenotypes.  
Interrogating high-dimensional metabolomic data calls for several analytical tools: multiple 
hypothesis testing with false discovery rate (FDR) adjustment, hierarchical clustering, principal 
components analysis (PCA), partial least squares (PLS), biochemical pathway enrichment and network 
analysis [6,7]. With these tools, difficult and complex analyses of large amounts of data can be more 
easily accomplished and interpreted. 
Little is presently known about the metabolic phenotypes of the gut microbiome nor whether those 
can be estimated by analyzing feces, a more readily accessible specimen, particularly in clinical contexts. 
Therefore, we compared the metabolic profiles of the colonic-cecal luminal contents and recently 
collected feces of C57BL/6 mice fed a standard chow-type diet. These baseline data can inform studies of 
the host-gut environment and the whether fecal analyses may be informative in such studies. 
2. Results and Discussion 
2.1. Metabolomic Comparisons of Sample Types 
A total of 270 metabolites were identified in the colonic-cecal contents and feces. Of these 251 (93%) 
metabolites were found in both types of specimen. Only 19 showed metabolites unique patterns (eight 
found only in colonic-cecal contents; 11 found only in feces) (Figure 1); however, 115 metabolites 
showed significantly different relative abundances in colonic-cecal contents vs. feces  
(padj < 0.05) (Figure 1, Table S1). Metabolic pathway enrichment analysis revealed that these 115 
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metabolites fell into 21 biochemical pathways (as defined by Kyoto Encyclopedia of Genes and 
Genomes, KEGG [8]), which were mainly related to amino acid, lipid metabolism, rare amino acids, 
cofactors, vitamins, signaling molecules, nitrogen, energy, and human disease/cancer. 
 
Figure 1. Overview of significant differences in metabolite profiles between colonic 
mucosal, colonic-cecal content and feces sample type comparisons. 
In this study, the chow diet contained 15.5% fiber (including crude and detergent fiber, e.g., cellulos, 
hemi-cellulose and lignin according to product data analysis (LabDiet cat#5015, St. Louis, MO). Certain 
dietary fibers are fermentable, and can alter gut microbiota composition. It is known that the gut 
microbiota is exposed to substrates that have escaped digestion in the upper gastrointestinal tract, or have 
been released into the lumen in the form of mucous and sloughed cells [9,10], and that their fermentation 
produced short chain fatty acids (SCFAs) [10]. Accordingly, the metabolite patterns we found 
demonstrate the presence of metabolic pathways involved the metabolism of lipids and amino acids. 
2.2. Metabolites Unique To Colonic-Cecal Contents or Feces 
Certain metabolites were found only in colonic-cecal contents or feces. Eight found only in  
colonic-cecal contents were related mostly to the metabolism of lipids, amino acids and nucleotides as 
well as to digestion and carcinogenesis (Table 1). Eleven metabolites found only in feces were related 
to the metabolism of lipids, amino acids and some vitamins, as well as glycan biosynthesis, digestion 
system and carcinogenesis (Table 1). The relative abundances of these unique metabolites were included 
in (Table S1). 
  
8 251 11
cecal contents feces
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Table 1. Unique metabolites and their respective biochemical pathways in colonic-cecal 
contents and feces. 
Colon-cecal contents  Feces 
Unique metabolites 
1-Hexadecanoyl-2-octadecadienoyl-sn-glycero-
3-phosphocholine 
1H-Indole-3-carboxylic acid 
L-Alanyl-L-norleucine 1-Myristoyl-sn-glycero-3-phosphocholine 
Leu-Val 1-Octadecanoyl-sn-glycero-3-phosphocholine 
N-Palmitoylsphingosine Betaine 
Palmityl-L-carnitine L-Carnitine 
Pregnan-20-one, 17-(acetyloxy)-3-hydroxy-6-
methyl-, (3b,5b,6a)-(A) 
Nicotinamide adenine dinucleotide (NAD) 
3a,12b-Dihydroxy-5b-cholanoic acid-(A) Oxyquinoline 
Deoxythymidine monophosphate (dTMP) 
 
Pregnan-20-one, 17-(acetyloxy)-3-hydroxy-6-methyl-, 
(3b,5b,6a)-(B) 
 13-hydroxy-9Z,11E-octadecadienoic acid 
 3a,12b-Dihydroxy-5b-cholanoic acid-(B) 
 UDP-N-acetyl-D-galactosamine 
Respective biochemical pathways 
Ether lipid metabolism Primary bile acid biosynthesis 
Glycerophospholipid metabolism Tryptophan metabolism 
Metabolic pathways Biosynthesis of secondary metabolites 
Choline metabolism in cancer Ether lipid metabolism 
Valine, leucine and isoleucine degradation / 
biosynthesis 
Glycerophospholipid metabolism 
Sphingolipid metabolism Metabolic pathways 
Bile secretion Choline metabolism in cancer 
Fatty acid degradation Glycine, serine and threonine metabolism 
Steroid hormone biosynthesis ABC transporters 
Secondary bile acid biosynthesis Bile secretion 
Pyrimidine metabolism Fatty acid degradation 
 Folate biosynthesis 
 Nicotinate and nicotinamide metabolism 
 Quinolines 
 Phenylalanine, tyrosine and tryptophan biosynthesis 
 Steroid hormone biosynthesis 
 Biosynthesis of unsaturated fatty acids 
 Linoleic acid metabolism 
 Secondary bile acid biosynthesis 
 Mucin type O-Glycan biosynthesis 
 Amino sugar and nucleotide sugar metabolism 
 Mucin type O-Glycan biosynthesis 
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Their largely similar metabolite profiles indicate the presence of the same functional pathways in both 
colonic-cecal contents and feces. Only 7% of metabolites were unique to colonic-cecal contents or feces. 
These may have utility as signature molecules for these specimens. The presence only in colonic-cecal 
contents of peptides (Leu-Val, L-Alanyl-L-norleucine) and metabolites of bile acids, steroids, lipids and 
nucleotides (1-Hexadecanoyl-2-octadecadienoyl-sn-glycero-3-phosphocholine; Palmityl-L-carnitine; 
pregnan-20-one,17-(acetyloxy)-3-hydroxy-6-methyl-(3b,5b,6a)-(A); 3a, 12b-dihydroxy-5b-cholanoic  
acid-(A); N-palmitoylsphingosine, deoxythymidine monophosphate) is consistent with the fact that the 
complete peptide-breakdown only occurs in colonic segment [11–14], and cecum also plays a critical 
role in bile secretion and steroid and lipid metabolism [15]; whereas, the presence only in feces of 
metabolites of amino acids, bile acids and lipids (1H-Indole-3-carboxylic acid; betaine; oxyquinoline, 
1-Myristoyl-sn-glycero-3-phosphocholine, 1-Octadecanoyl-sn-glycero-3-phosphocholine, L-Carnitine, 
3a,12b-Dihydroxy-5b-cholanoic acid-(B)), some fats, glycans and heterocylic compounds (NAD;  
13-hydroxy-9Z, 11E-octadecadienoic acid; UDP-N-acetyl-D-galactosamine; oxyquinoline) is consistent 
with bacterial fermentation in the distal colon [9,16]. However, we cannot be sure the extent to which 
the latter metabolites may have been produced under aerobic conditions after defecation. 
2.3. Metabolite Patterns and Networks 
Comparisons of the relative abundances of the 270 metabolites found in these specimens are shown 
as a heat map [17] (Figure 2). As the smaller bracket (at the top of Figure 2) represents the higher 
similarity in abundance between individual samples, the data show that samples within a given sample 
type (e.g., cecal contents or feces) shared very similar patterns (Figure 2). The cecal contents and feces 
also shared an overall similar metabolite profiles with only a few distinct patterns because feces were  
downstream-products of colonic-cecal contents via colonic fermentation (Figure 2, Table S1). 
Orthogonal signal correction partial least squares discriminant analysis (O-PLS-DA) [18] was used to 
develop a multivariate classification model for these two sample types. The two latent variable (X and 
Y axis) for an O-PLS-DA model (Figure 3), can be used to evaluate within- and between-group 
similarities between samples, and the smaller values of latent the more similar [6,18]. As latent variables 
of metabolites in cecal contents were smaller than that of feces (Figure 3), it suggests that inter individual 
variance data within cecal content group are less different than that of feces samples (Figure 3) [19]. 
This suggests that future metabolite profiling studies would require fewer samples of colonic-cecal 
contents than that of feces within a treatment group. 
Biochemical network analysis (defined by KEGG) revealed that the abundance of most carbohydrate 
metabolites (e.g., galactose-6-phosphase, erythrose), and amino acid metabolites (e.g., glutamic acid, 
aspartic acid, leucine, valine) were greater in colonic cecal contents than that in feces (Figure 4, Table 
S1). This is in agreement with the fact that complex carbohydrates and poorly digested proteins may 
reach the hind gut to be available for colonic bacterial fermentation [11–14,20]. In contrast, the contents 
of most fatty acid-related metabolites (e.g., linoleic acid, jasmonic acid, and phospholipid) were greater 
in feces than in colonic-cecal contents (Figure 4, Table S1). The higher content of phospholipid in feces 
may reflect bacterial breakdown [12,21].  
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Collectively, the metabolite detection, unique metabolites, relative abundance comparison and 
network analyses are the key methods to study the gut metabolome in our future nutritional  
intervention experiments. 
feces  cecal contents 
 
Figure 2. The heatmap displays relative increase/decrease of metabolite contents and their 
similarities between individual samples. In these visualization columns represent samples 
and rows variables, and hierarchical cluster analysis (HCA) was used to group samples and 
metabolites based on similarities in auto-scaled values and correlations, respectively. Cluster 
identities represent differing experimental biological or analytical variability; colors (red, 
relative increase; blue, relative decrease). 
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Figure 3. Orthogonal signal correction partial least squares discriminant analysis  
(O-PLS-DA) was used to generate a multivariate classification model showing the 
relationship of the variance (in metabolites) and sample types (colonic-cecal content and 
feces). X and Y axis are O-PLS-DA sample scores for the first two latent variables. Color 
codes: pink, colonic-cecal contents; blue, feces. 
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Figure 4. Biochemical and chemical similarity network highlighting important differences 
in metabolites abundance between colonic-cecal content and feces. Vertex size encodes the 
fold change in metabolite abundance between groups (when the metabolite abundance in 
colonic-cecal content was higher than that in feces, we defined it as “increase”; in contrast, 
if the metabolite abundance in colonic-cecal content was lower than that in feces, we defined 
it as “decrease”). Vertex shape (triangle, increase; “V”, decrease; ellipse, no change) and 
color (blue, decrease; red, increase; gray, insignificant change or p > 0.05 after-adjustment 
for FDR) are used to encode the significance and relative direction of changes in metabolites 
between colonic-cecal content and feces comparison. 
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3. Experimental Section 
3.1. Animals, Diets, and Treatment 
This study was approved by the Animal Care and Use Committee of the Grand Forks Human 
Nutrition Research Center, and animals were maintained in accordance with NIH guidelines for the care 
and use of laboratory animals. Male C57BL/6 mice, 5 months old and body weight (30 g), were 
individually housed in Plexiglas ventilated cages within a pathogen-free facility that maintained a  
12-h light/dark cycle. Mice (n = 5) were given free access to deionized water, and a common  
practical-type, chow diet (LabDiet cat#5015, St. Louis, MO). This chow diet is a complete life cycle diet, 
in which 19.8% calories from protein, 26.1% calories from fat (ether extract) and 54.1% calories from 
carbohydrates. These mice had been in this diet for 5 months (their entire life time). At the termination 
of the experiment, mice were euthanized with a mixture of ketamine and xylazine by intraperitoneal 
injection. Feces were collected over a 24-h period prior to euthanasia. After euthanasia, the gut was 
prepared by dissection, the colonic and cecal contents were combined, and all samples were placed in 
sealed containers and held at −80 °C prior to analysis. 
3.2. Sample Extraction 
Aliquots (10 mg) of colonic-cecal contents and feces were each thawed and extracted by agitation 
with 1mL of degassed acetonitrile: isopropanol: water (3:3:2) at –20 °C after which the soluble portion 
was recovered by centrifugation. Aliquots (450 µL) of that supernate were used for each GC-TOF and 
LC-Q-TOF analyses. 
3.3. GC-TOF Analysis 
Extracts were derivatized as previously published [22], and then analyzed using an Agilent 7890A 
gas chromatograph (Santa Clara, CA) coupled to a Leco Pegasus IV time-of-flight mass spectrometer. 
A Gerstel MPS2 automatic liner exchange system (ALEX) was used to eliminate sample  
cross-contamination during the GC-TOF analysis. The column was 30 m, 0.25 mm i.d. Rtx5Sil-MS with 
0.25 µm 5% diphenyl film with a 10 m integrated guard column (Restek, Bellefonte PA) [23–25]. The 
sample (0.5 µL) was injected at 50 °C ramped to 250 °C in splitless mode with a 25 s splitless time. The 
chromatographic gradient consisted of a constant flow of 1 ml/min, ramping the oven temperature from 
50 °C for to 330 °C over 22 min. Mass spectrometry parameters were: 280 °C transfer line temperature, 
electron ionization at −70 V, and a 250 °C ion source temperature. Mass spectra were acquired at 1525 
V detector voltage at m/z 85–500 with 17 spectra/sec. Acquired spectra were further processed using the 
BinBase database [25–27]. Data quality and instrument performance were monitored throughout the data 
acquisition using quality control and reference plasma samples (NIST), as previously described [22]. 
3.4. LC-Q-TOF Data Collection and Analysis 
Extracts were evaporated to dryness under reduced pressure, and reconstituted in 50 µL of 
water:acetonitrile (98:2 v:v), sonicated (5 min) and, then, centrifuged. Supernates (40 µL) were 
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transferred to amber glass vials (National Scientific-C4000-2W) fitted with micro-inserts (Supelco 
27400-U). 
Polar extracts were analyzed using an Agilent 1290 A Infinity Ultra High Performance Liquid 
Chromatography system coupled to an Agilent Accurate Mass-6530-QTOF in both positive and negative 
modes. The column (40 °C) was a Waters Acquity BEH Shield RP18 Column (150 mm length x 2.1 mm 
internal diameter; 1.7 µM particles). Mobile Phase A consisted of 100% LCMS grade water containing 
0.1% formic acid; mobile phase B consisted of 100% acetonitrile containing 0.1% formic acid. The 
gradient started from 0 min 2% (B), 0–0.5 min 2% (B), 0.5–12 min 95% (B), 12–12.5 min 95% (B), 
12.5–12.6 min 2% (B), and 12.6 min–17 min 2% (B). The flow rate was 0.6 mL/min; an injection volume 
was 5 µL for both ESI (+/−) mode acquisitions with an ESI capillary voltage was  
+ 3.5 kV and −3.5 kV for positive and negative mode, respectively. For MSMS, collision energies were 
10, 20 and 40 eV for both positive and negative acquisition modes. Data were collected over a mass 
range of m/z 60–1200 Da with a spectral acquisition speed of 2 spectra per sec. 
Data were processed using MZmine 2.10. All peak intensities are representative of peak heights. 
Annotations were completed by matching experimental accurate mass MS/MS spectra to MS/MS 
libraries, including Metlin-MSMS, NIST12, and LipidBlast. Spectral matching was accomplished using 
MSPepSearch manually curated using The NIST Mass Spectral Search Program Version 2.0g. 
Metabolite libraries were created, in positive and negative ionization modes, containing all confirmed 
identified compounds. MZmine’s Custom Database Search tool was used to assign annotations based on 
accurate mass and retention time matching. 
3.5. Data Analysis 
Data collected by GC-TOF and LC-Q-TOF were merged for both types of sample. GC-TOF values 
are reported for metabolic features measured on both platforms with analysis limited to annotated 
features. Missing values for the LC-Q-TOF were imputed as zeros. Statistical analyses were conducted 
on natural logarithm-transformed metabolic parameters, and data summaries are presented for raw 
values. Multivariate analyses (clustering, PCA, O-PLS-DA) were implemented on natural logarithm-
transformed and auto-scaled values (mean centered and scaled by the standard deviation, z-scaled). 
Statistical analyses were implemented in R v3.01. Independent sample t-Tests were used to test for 
differences in metabolite profiles between colonic-cecal contents and feces. The probability or significance 
level for the test statistics (i.e., p-values) were adjusted for the multiple hypotheses tested [28], and the 
false discovery rate (FDR)-adjusted p-values are reported as “padj”. The FDR was also directly estimated 
as the q-value, for all comparisons [29]. Hierarchical cluster analysis (HCA) was used to group samples 
and metabolites based on similarities in auto-scaled values and correlations, respectively [6]. Principal 
components analysis [6] was used to evaluate the sample class structure including similarities and 
differences. Orthogonal signal correction partial least squares discriminant analysis (O-PLS-DA) [18] 
was used to develop a multivariate classification model for the two types of samples. In order to visualize 
the biological interrelationship of the 270 known metabolites in colonic cecal contents and feces, 
biochemical and chemical similarity network analysis was used to generate networks vertices based on 
biochemical relationships (KEGG RPAIR Database). 
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4. Conclusions 
In summary, we have conducted the first comprehensive comparison of the metabolite profiles of 
colonic-cecal contents and feces in the mouse. Our results show that these specimens have very similar 
metabolite profiles, indicating the suitability of feces, which can be sampled non-invasively, as proxies 
for estimating the metabolite patterns of hindgut microbiome. These findings should inform future 
research on the role of diet and the gut microbiome in supporting health. 
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